Shopping Cart
- Remove All
- Your shopping cart is currently empty
Phenazopyridine hydrochloride (Pyridium) is used orally as a urinary tract analgesic. Side effects of phenazopyridine hydrochloride administration can include nausea, interference with the oxygen-carrying capacity of red blood cells (methemoglobinemia), hemolytic anemia as well as renal and hepatic toxicity. It is reasonably anticipated to be a human carcinogen.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | $38 | In Stock | |
100 mg | $47 | In Stock | |
200 mg | $66 | In Stock | |
1 mL x 10 mM (in DMSO) | $50 | In Stock |
Description | Phenazopyridine hydrochloride (Pyridium) is used orally as a urinary tract analgesic. Side effects of phenazopyridine hydrochloride administration can include nausea, interference with the oxygen-carrying capacity of red blood cells (methemoglobinemia), hemolytic anemia as well as renal and hepatic toxicity. It is reasonably anticipated to be a human carcinogen. |
In vitro | Phenazopyridine directly inhibits the mechanical sensitivity of Aδ-fibers in the bladders of normal rats. |
In vivo | Phenazopyridine enhances cell viability, strengthens neuronal cell differentiation, synchronizes the state of cell differentiation, and reduces the number of non-neuronal and undifferentiated cells. |
Alias | Urodine, Pyridium, Phenazopyridine HCl |
Molecular Weight | 249.7 |
Formula | C11H12ClN5 |
Cas No. | 136-40-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 10 mg/mL (40.05 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.